Biodexa Pharmaceuticals PLC Result of General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing a pipeline of ...

I Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.

While Bryan was making his observations with the CD8–ζ chain chimera, a very talented group of postdoctoral fellows in my laboratory were on the hunt for a TCR-associated tyrosine kinase that ...

There are conflicting data regarding the effects of TK inhibitors on tumor immunity (Table 2). Some reports demonstrated the immunostimulatory effects of a TK inhibitor, but others reported the ...

BACKGROUND: Recent studies have highlighted the deleterious role of high phosphate intake in hypertension by means of ...

The strategies for targeting the ANGPT–TIE system range from developing receptor tyrosine kinase inhibitors (TKIs; to target TIE2), as well as selective and non-selective traps (to target ANGPT1 ...

Many people with diabetes need to use insulin to manage their blood sugar. But this vital medication often has a frustrating side effect: weight gain. When people with type 1 or type 2 diabetes ...

Last October Novo Nordisk announced that it had shelved plans to bring the world’s first oral insulin to market . But the company has just presented early stage data showing the formulation to ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Precision oncology led to the establishment ...